Widdop Robert E, Matrougui Khalid, Levy Bernard I, Henrion Daniel
Department of Pharmacology, Monash University, Melbourne, Victoria, Australia.
Hypertension. 2002 Oct;40(4):516-20. doi: 10.1161/01.hyp.0000033224.99806.8a.
Angiotensin II type 2 receptor (AT2R) stimulation may cause vasodilation per se and may contribute to the antihypertensive effect produced by Angiotensin II type 1 receptor (AT1R) antagonists, given that AT1R blockade increases endogenous levels of Ang II, suggesting a physiological role for the unblocked AT2R. Thus, we first directly assessed whether or not there is desensitization to AT2R-mediated vasorelaxation because this is an important consideration, given the raised Ang II levels and the marked desensitization that is known to occur after AT1R stimulation. Second, we examined if AT2R-mediated vasorelaxation is preserved after long-term treatment with the AT1R antagonist candesartan cilexetil. Consecutive concentration-response curves to AT2R stimulation, with either Ang II (with AT1R blockade) or the selective agonist CGP42112, were studied in rat isolated mesenteric resistance arteries mounted in an arteriograph. AT2R stimulation with Ang II induced a concentration-dependent relaxation without desensitization. Similarly, CGP42112 evoked highly reproducible relaxation, which, like Ang II, was abolished by the AT2R antagonist PD123319. By contrast, AT1R-mediated contraction exhibited marked desensitization. In rats treated with candesartan cilexetil (2 mg/kg per day for 2 weeks), AT1R-mediated contraction was abolished, whereas AT2R-mediated relaxation evoked by either Ang II or CGP42112 was highly reproducible, PD123319-sensitive, and of a magnitude similar to that observed in naïve animals. Therefore, this study has provided unequivocal evidence for the reproducible nature of AT2R-mediated vasorelaxation during short-term and long-term AT1R blockade. Such preservation of AT2R function is a prerequisite for the consideration of physiological role(s) of AT2R during AT1R blockade.
血管紧张素II 2型受体(AT2R)的刺激本身可能会引起血管舒张,并且可能有助于血管紧张素II 1型受体(AT1R)拮抗剂产生的降压作用,因为AT1R阻断会增加内源性血管紧张素II的水平,这表明未被阻断的AT2R具有生理作用。因此,鉴于血管紧张素II水平升高以及已知在AT1R刺激后会发生明显的脱敏现象,这是一个重要的考虑因素,我们首先直接评估是否存在对AT2R介导的血管舒张的脱敏。其次,我们研究了用AT1R拮抗剂坎地沙坦酯长期治疗后,AT2R介导的血管舒张是否得以保留。在安装于血管造影仪中的大鼠离体肠系膜阻力动脉中,研究了对AT2R刺激的连续浓度-反应曲线,刺激物为血管紧张素II(同时阻断AT1R)或选择性激动剂CGP42112。用血管紧张素II刺激AT2R可诱导浓度依赖性舒张且无脱敏现象。同样,CGP42112引起高度可重复的舒张,与血管紧张素II一样,被AT2R拮抗剂PD123319所阻断。相比之下,AT1R介导的收缩表现出明显的脱敏。在用坎地沙坦酯(每天2 mg/kg,持续2周)治疗的大鼠中,AT1R介导的收缩被消除,而由血管紧张素II或CGP42112引起的AT2R介导的舒张是高度可重复的、对PD123319敏感的,并且其幅度与在未处理动物中观察到的相似。因此,本研究为短期和长期AT1R阻断期间AT2R介导的血管舒张的可重复性提供了明确证据。AT2R功能的这种保留是在AT1R阻断期间考虑AT2R生理作用的先决条件。